Sale!

SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant NGS Genetic DNA Test is a specialized diagnostic tool that identifies mutations in the SOST gene responsible for this rare bone disorder. Using next-generation sequencing technology, this test provides comprehensive analysis of the SOST gene to detect pathogenic variants that cause progressive cranial and skeletal hyperostosis. The test is crucial for individuals showing symptoms of abnormal skull growth, facial deformities, hearing loss, or vision problems. Results help confirm diagnosis, guide treatment decisions, and provide essential information for family planning. Available for $500 USD, this advanced genetic testing offers peace of mind and medical clarity for affected individuals and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant NGS Genetic DNA Test

Comprehensive Genetic Testing for Craniodiaphyseal Dysplasia

The SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the SOST gene that cause this rare and progressive bone disorder. Craniodiaphyseal dysplasia is characterized by abnormal bone growth, particularly affecting the skull and facial bones, leading to distinctive facial features and potential neurological complications. This advanced genetic test provides crucial information for accurate diagnosis, treatment planning, and genetic counseling.

What This Test Measures and Detects

Our comprehensive NGS-based test specifically analyzes the SOST (sclerostin) gene for pathogenic variants associated with craniodiaphyseal dysplasia. The test detects:

  • Point mutations in the SOST gene coding regions
  • Small insertions and deletions affecting gene function
  • Autosomal dominant inheritance pattern confirmation
  • Specific genetic variants linked to progressive skeletal hyperostosis
  • Mutations affecting sclerostin production and bone metabolism regulation

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with:

  • Progressive cranial hyperostosis and skull thickening
  • Facial bone overgrowth leading to distinctive facial features
  • Hearing loss or vision impairment due to bone compression
  • Family history of craniodiaphyseal dysplasia or similar bone disorders
  • Unexplained skeletal abnormalities in childhood
  • Developmental delays associated with cranial abnormalities
  • Neurological symptoms resulting from foraminal narrowing

Key Benefits of SOST Gene Testing

Choosing our comprehensive genetic testing provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out craniodiaphyseal dysplasia with high precision
  • Early Intervention: Enables timely medical management and treatment planning
  • Family Planning: Provides essential information for genetic counseling and reproductive decisions
  • Treatment Guidance: Helps healthcare providers develop targeted treatment strategies
  • Peace of Mind: Reduces diagnostic uncertainty and provides clear answers
  • Research Contribution: Advances understanding of rare bone disorders

Understanding Your Test Results

Our genetic counseling team provides comprehensive result interpretation:

  • Positive Result: Indicates the presence of a pathogenic SOST gene mutation, confirming craniodiaphyseal dysplasia diagnosis
  • Negative Result: Suggests absence of known SOST mutations, though clinical correlation is essential
  • Variant of Uncertain Significance: Requires additional family studies and clinical evaluation
  • Carrier Status: Important information for family members and future generations

All results include detailed genetic counseling to ensure proper understanding and next steps.

Test Pricing and Details

Test Component Details
Test Name SOST Gene Craniodiaphyseal Dysplasia Autosomal Dominant NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We have convenient testing locations across the United States, including major cities such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about craniodiaphyseal dysplasia affect your health decisions. Our specialized genetic testing provides the answers you need for proper diagnosis and management. Contact our genetic counseling team today to schedule your test and begin your journey toward medical clarity.

Call or WhatsApp us now at +1(267) 388-9828 to book your SOST Gene Craniodiaphyseal Dysplasia NGS Genetic DNA Test and take advantage of our special $500 pricing.